 Sanchayita Sen
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Hemorrhagic | 6 | 2023 | 167 | 2.530 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 173 | 1.320 |
Why?
| | Proteomics | 6 | 2023 | 1111 | 1.180 |
Why?
| | Capillary Permeability | 2 | 2023 | 145 | 1.010 |
Why?
| | Wounds and Injuries | 3 | 2023 | 758 | 0.930 |
Why?
| | Neutrophils | 10 | 2022 | 1238 | 0.930 |
Why?
| | Calcium | 4 | 2023 | 1199 | 0.890 |
Why?
| | Endothelial Cells | 4 | 2023 | 785 | 0.880 |
Why?
| | Hypocalcemia | 1 | 2023 | 27 | 0.830 |
Why?
| | Brain Injuries, Traumatic | 3 | 2023 | 360 | 0.810 |
Why?
| | Plasminogen Activator Inhibitor 1 | 3 | 2022 | 86 | 0.800 |
Why?
| | Serpins | 1 | 2022 | 31 | 0.790 |
Why?
| | Complement C4 | 1 | 2022 | 28 | 0.770 |
Why?
| | Neutrophil Activation | 6 | 2006 | 80 | 0.770 |
Why?
| | Pericytes | 1 | 2022 | 34 | 0.760 |
Why?
| | Blast Injuries | 1 | 2022 | 48 | 0.740 |
Why?
| | Balloon Occlusion | 1 | 2022 | 34 | 0.740 |
Why?
| | Calcium Signaling | 1 | 2023 | 249 | 0.730 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.730 |
Why?
| | Hemolysis | 1 | 2022 | 206 | 0.700 |
Why?
| | Arginine | 1 | 2022 | 271 | 0.700 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.680 |
Why?
| | Astrocytes | 1 | 2022 | 210 | 0.660 |
Why?
| | Endothelium, Vascular | 2 | 2023 | 927 | 0.660 |
Why?
| | Saline Solution, Hypertonic | 4 | 2022 | 41 | 0.620 |
Why?
| | Fibrinolysis | 2 | 2022 | 146 | 0.620 |
Why?
| | Endovascular Procedures | 1 | 2022 | 312 | 0.560 |
Why?
| | Brain Injuries | 1 | 2022 | 494 | 0.530 |
Why?
| | Proto-Oncogene Proteins c-hck | 1 | 2016 | 1 | 0.520 |
Why?
| | Lysophosphatidylcholines | 1 | 2016 | 22 | 0.520 |
Why?
| | Protein Kinase C | 2 | 2016 | 261 | 0.510 |
Why?
| | Protein Kinase C-delta | 1 | 2016 | 48 | 0.500 |
Why?
| | NADPH Oxidases | 1 | 2016 | 113 | 0.500 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 224 | 0.480 |
Why?
| | Multiple Organ Failure | 3 | 2022 | 128 | 0.420 |
Why?
| | NF-kappa B | 9 | 2017 | 691 | 0.410 |
Why?
| | Cytokines | 10 | 2022 | 2085 | 0.400 |
Why?
| | Protein C | 2 | 2023 | 59 | 0.400 |
Why?
| | Cell Membrane | 1 | 2016 | 738 | 0.400 |
Why?
| | Thrombelastography | 4 | 2023 | 154 | 0.390 |
Why?
| | Swine | 3 | 2023 | 775 | 0.370 |
Why?
| | Resuscitation | 2 | 2022 | 251 | 0.320 |
Why?
| | Hemorrhage | 3 | 2022 | 722 | 0.320 |
Why?
| | Enzyme Activation | 7 | 2016 | 810 | 0.310 |
Why?
| | Cells, Cultured | 7 | 2023 | 4193 | 0.280 |
Why?
| | Epithelial Cells | 3 | 2017 | 1096 | 0.270 |
Why?
| | Histones | 2 | 2022 | 636 | 0.270 |
Why?
| | Receptors, Immunologic | 2 | 2005 | 216 | 0.270 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.250 |
Why?
| | Inflammation | 5 | 2023 | 2837 | 0.230 |
Why?
| | Signal Transduction | 7 | 2017 | 5079 | 0.230 |
Why?
| | Receptors, Cell Surface | 2 | 2004 | 385 | 0.230 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2005 | 54 | 0.230 |
Why?
| | Lipopolysaccharides | 6 | 2006 | 886 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 3 | 2005 | 648 | 0.230 |
Why?
| | Membrane Glycoproteins | 2 | 2004 | 500 | 0.220 |
Why?
| | Oxidants | 2 | 2004 | 111 | 0.220 |
Why?
| | TRPV Cation Channels | 1 | 2023 | 40 | 0.210 |
Why?
| | Humans | 19 | 2023 | 137585 | 0.210 |
Why?
| | Phosphorylation | 5 | 2016 | 1759 | 0.210 |
Why?
| | Protein Transport | 4 | 2016 | 445 | 0.200 |
Why?
| | Lung | 4 | 2017 | 4060 | 0.200 |
Why?
| | Thrombophilia | 1 | 2023 | 83 | 0.200 |
Why?
| | Arginase | 1 | 2022 | 32 | 0.200 |
Why?
| | Multiple Trauma | 1 | 2023 | 100 | 0.200 |
Why?
| | Tight Junction Proteins | 1 | 2022 | 15 | 0.190 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2022 | 86 | 0.190 |
Why?
| | Citrulline | 1 | 2022 | 45 | 0.190 |
Why?
| | Dust | 1 | 2022 | 100 | 0.190 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 528 | 0.190 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 110 | 0.190 |
Why?
| | Hydrogen Peroxide | 1 | 2003 | 328 | 0.190 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 366 | 0.190 |
Why?
| | Animals | 14 | 2023 | 36940 | 0.190 |
Why?
| | Endotoxins | 1 | 2022 | 220 | 0.180 |
Why?
| | Mice, Inbred BALB C | 8 | 2006 | 1272 | 0.180 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 194 | 0.170 |
Why?
| | Plasma | 1 | 2022 | 212 | 0.170 |
Why?
| | Thrombosis | 1 | 2023 | 371 | 0.160 |
Why?
| | Male | 13 | 2023 | 67762 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 496 | 0.150 |
Why?
| | Complement Activation | 1 | 2022 | 415 | 0.150 |
Why?
| | Water | 1 | 2022 | 460 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 4 | 2006 | 283 | 0.150 |
Why?
| | Nitric Oxide | 1 | 2022 | 915 | 0.140 |
Why?
| | Pilot Projects | 1 | 2022 | 1710 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2006 | 437 | 0.130 |
Why?
| | RNA, Messenger | 3 | 2022 | 2833 | 0.130 |
Why?
| | Transcription Factor RelA | 4 | 2014 | 87 | 0.130 |
Why?
| | Mice | 10 | 2016 | 17787 | 0.120 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 162 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 3 | 2005 | 115 | 0.120 |
Why?
| | Superoxides | 1 | 2006 | 202 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1242 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2023 | 4295 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2005 | 152 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 185 | 0.110 |
Why?
| | Injury Severity Score | 1 | 2016 | 522 | 0.100 |
Why?
| | Lung Injury | 1 | 2016 | 219 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 852 | 0.100 |
Why?
| | Recombinant Proteins | 1 | 2016 | 1353 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2014 | 372 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 622 | 0.100 |
Why?
| | Phospholipases A2, Secretory | 1 | 2012 | 12 | 0.090 |
Why?
| | Cell Movement | 2 | 2017 | 967 | 0.090 |
Why?
| | Kringles | 2 | 2006 | 5 | 0.090 |
Why?
| | Urokinase-Type Plasminogen Activator | 2 | 2006 | 29 | 0.090 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 139 | 0.090 |
Why?
| | Enzyme Inhibitors | 2 | 2012 | 840 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2016 | 916 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2224 | 0.080 |
Why?
| | Adult | 3 | 2023 | 37929 | 0.080 |
Why?
| | Mice, Knockout | 1 | 2016 | 3015 | 0.080 |
Why?
| | Cell Nucleus | 4 | 2017 | 620 | 0.070 |
Why?
| | Peptidoglycan | 2 | 2005 | 23 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2005 | 313 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1457 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.070 |
Why?
| | Toll-Like Receptor 4 | 3 | 2005 | 273 | 0.070 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.060 |
Why?
| | Toll-Like Receptors | 2 | 2004 | 185 | 0.060 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 98 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2006 | 2167 | 0.060 |
Why?
| | Integrin alphaVbeta3 | 1 | 2005 | 18 | 0.060 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2005 | 12 | 0.060 |
Why?
| | I-kappa B Kinase | 3 | 2006 | 55 | 0.060 |
Why?
| | Drug Synergism | 2 | 2006 | 382 | 0.060 |
Why?
| | src Homology Domains | 1 | 2005 | 41 | 0.060 |
Why?
| | Up-Regulation | 2 | 2005 | 843 | 0.060 |
Why?
| | Protein Kinases | 2 | 2004 | 319 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2012 | 940 | 0.060 |
Why?
| | HMGB1 Protein | 1 | 2005 | 50 | 0.060 |
Why?
| | Female | 3 | 2023 | 73304 | 0.060 |
Why?
| | Chemokine CXCL2 | 1 | 2004 | 43 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2003 | 92 | 0.050 |
Why?
| | Thromboplastin | 1 | 2023 | 74 | 0.050 |
Why?
| | Chemokines | 1 | 2004 | 228 | 0.050 |
Why?
| | Down-Regulation | 1 | 2005 | 657 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2003 | 316 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 353 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2022 | 107 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 255 | 0.040 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2006 | 124 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2828 | 0.040 |
Why?
| | Mitochondria | 1 | 2016 | 948 | 0.040 |
Why?
| | Middle Aged | 2 | 2023 | 33479 | 0.040 |
Why?
| | Anticoagulants | 1 | 2023 | 664 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2012 | 2526 | 0.040 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2017 | 13 | 0.040 |
Why?
| | Chemokine CCL5 | 1 | 2017 | 43 | 0.040 |
Why?
| | Metabolomics | 1 | 2023 | 678 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2017 | 72 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 149 | 0.030 |
Why?
| | Chemotaxis | 1 | 2017 | 131 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2003 | 1317 | 0.030 |
Why?
| | Paraquat | 1 | 2006 | 14 | 0.030 |
Why?
| | Phosphoserine | 1 | 2006 | 34 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 311 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 514 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 171 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 5742 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 402 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 510 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2757 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 976 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 286 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1226 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1996 | 0.020 |
Why?
| | Cell Line | 1 | 2014 | 2847 | 0.020 |
Why?
| | Rats | 1 | 2017 | 5647 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.020 |
Why?
| | Protein Kinase C beta | 1 | 2005 | 21 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 2005 | 37 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2004 | 54 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 45 | 0.010 |
Why?
| | Enzyme Stability | 1 | 2004 | 70 | 0.010 |
Why?
| | alpha-Tocopherol | 1 | 2004 | 33 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3412 | 0.010 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2004 | 30 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2004 | 81 | 0.010 |
Why?
| | Acetylcysteine | 1 | 2004 | 145 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1092 | 0.010 |
Why?
| | Antibodies | 1 | 2005 | 410 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2004 | 513 | 0.010 |
Why?
| | Antioxidants | 1 | 2004 | 584 | 0.010 |
Why?
|
|
Sen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|